Stock message boards
MNV
Market News Video
MNV MNV 10 Oversold Stocks You Need To Know About
MNV
MNV
MNV
MNV
MNV
MNV
MNV
Free Dividend Report - Top Ranked Stocks

Featured MNV Articles:

Eaton Corp Moves Up In Analyst Rankings, Passing Biogen Idec
Friday, May 16, 11:52 AM ET, by Market News Video Staff

In a study of analyst recommendations at the major brokerages, for the underlying components of ...

AMRI: Insiders vs. Shorts
Friday, May 16, 2:48 PM ET, by Market News Video Staff

The most recent short interest data was recently released by the NASDAQ for the 04/30/2014 ...

Agilent Technologies Takes Over #228 Spot From Keurig Green Mountain
Thursday, May 22, 4:40 PM ET, by Market News Video Staff

In the latest look at the underlying components of the S&P 500 ordered by largest ...

Top Buys by Directors: Marth's $784.5K Bet on AMRI
Wednesday, May 28, 11:08 AM ET, by Market News Video Staff

The directors of a company tend to have a unique inside view into the business, ...

IBB, CELG, BIIB, REGN: ETF Inflow Alert
Wednesday, May 28, 11:20 AM ET, by Market News Video Staff

Symbols mentioned in this story: IBB, CELG, BIIB, REGN Exchange traded funds (ETFs) trade just ...

  More articles:  1 2 3 4 5 6 7 next »

Bullish Two Hundred Day Moving Average Cross - AMRI

By Market News Video Staff, Friday, June 3, 2:01 PM ET
Play Video: Learn About The 200 DMA


If the video does not load after a few moments, Upgrade to the Latest Flash Player.

In trading on Friday, shares of Albany Molecular Research, Inc. (NASDAQ:AMRI) crossed above their 200 day moving average of $5.41, changing hands as high as $5.42 per share. Albany Molecular Research, Inc. shares are currently trading up about 3.4% on the day. The chart below shows the one year performance of AMRI shares, versus its 200 day moving average:

Albany Molecular Research, Inc. 200 Day Moving Average Chart

Looking at the chart above, AMRI's low point in its 52 week range is $3.87 per share, with $7.10 as the 52 week high point that compares with a last trade of $5.39.

AMRI operates in the Biotechnology sector, among companies like Agilent Technologies, Inc. (NYSE:A) which is off about 0.8% today, and Biogen Idec Inc (NASDAQ:BIIB) trading higher by about 0.3%. Below is a three month price history chart comparing the stock performance of AMRI, versus A and BIIB.

AMRI,A,BIIB Relative Performance Chart


Free Trial: ''ETF CHANNEL FLEXIBLE GROWTH INVESTMENT PORTFOLIO''

The ETF Channel Flexible Growth Investment Portfolio is designed to seek growth for investors anywhere and everywhere. The key to the program is our portfolio strategy allows us complete flexibility in terms of asset allocation as there are no predetermined guidelines as to the level of stocks, bonds, cash, regions, countries, sectors, commodities, or even asset classes in the portfolio! In short, this is a completely flexible portfolio designed to follow the performance trail wherever it leads us.


Top Six Most Viewed Stories This Week @ Market News Video:

This Article's Word Cloud:   AMRI   Agilent   Albany   BIIB   Call   Crossing   Definition   Earnings   Growth   Molecular   Price   Research   Start   Their   Traded   Trial   about   above   allows   asset   average   changing   chart   commodities   currently   designed   flexibility   follow   high   history   level   month   moving   performance   point   portfolio   program   raquo   regions   sector   sectors   share   shares   that   trading   versus   week   wherever   which   with
MNV
MNV
About Us - Advertise - Contact Us - Embedding Videos - Licensing Videos - Partners - mRSS / RSS Feed - Terms of Use - Privacy Policy - Video Widget
MNV
Home  |  Analyst News  Dividend Report  Econonomic News  Insider Report  Large Caps  Market Movers  Week Ahead Report  Weekly Market Wrap
MNV
MNV MNV Stock Message Boards Stock Market Definitions
MNV

Bullish Two Hundred Day Moving Average Cross - AMRI | Market News Video | Copyright © 2008 - 2014, All Rights Reserved

Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners. In no way should any content contained herein be interpreted to represent trading or investment advice. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.